11 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 11 of 11 clinical reviews.
Clinical guide to using alprostadil (Caverject or MUSE) with apixaban (Eliquis). Covers the pharmacodynamic interaction mechanism, bleeding risk at the injection site, monitoring parameters, and what remains unverified.
A guide to the alprostadil and atorvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for men using both agents.
A guide to the alprostadil and diphenhydramine drug interaction, covering mechanism, cardiovascular risks, anticholinergic effects, monitoring, and patient counseling for men using Caverject or MUSE.
Does alprostadil interact with hormonal contraceptives? This MD-level guide covers mechanism, pharmacokinetics, clinical risk, monitoring, and patient counseling for Caverject and MUSE users.
Can you take alprostadil with ibuprofen or naproxen? A guide covering the pharmacodynamic overlap, bleeding risk, renal effects, monitoring protocols, and dose-adjustment strategies for combining Caverject or MUSE with NSAIDs.
Clinical analysis of the interaction between alprostadil (Caverject/MUSE) and proton pump inhibitors including omeprazole and pantoprazole. Covers pharmacokinetics, safety data, and monitoring recommendations.
Clinical guide to combining alprostadil (Caverject/MUSE) with prednisone: pharmacokinetic and pharmacodynamic interactions, monitoring parameters, dose adjustments, and patient counseling.
Clinical review of the alprostadil and pregabalin drug interaction, covering pharmacodynamic overlap, hypotension risk, monitoring parameters, and dose-adjustment guidance.
A guide to the alprostadil and rivaroxaban drug interaction, covering pharmacodynamic bleeding risk, mechanism, monitoring, and safe use in men with erectile dysfunction on anticoagulation.
A detailed clinical review of the alprostadil and simvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling based on FDA labels and primary literature.
Clinical guide to combining alprostadil (Caverject/MUSE) with SNRIs like venlafaxine and duloxetine. Covers mechanism, blood pressure risks, monitoring, dose adjustments, and patient counseling.